reference
Yousuf A, Ibrahim W, Greening NJ, and Brightling CE (2019) review T2 biologics for the treatment of chronic obstructive pulmonary disease (COPD).
Authors
Sources
- Chronic Inflammation - StatPearls - NCBI Bookshelf www.ncbi.nlm.nih.gov via serper